Navigation Links
Danaher CEO Comments on Outlook
Date:12/11/2008

WASHINGTON, Dec. 11 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) commented today on the performance outlook of the company for 2009. President and Chief Executive Officer H. Lawrence Culp, Jr. communicated the company expects 2009 earnings per share to be in the range of $3.70 to $4.10.

Mr. Culp stated, "We have taken significant steps to prepare our businesses for what we believe will be a difficult year ahead. However, despite the current economic backdrop, we believe we are well positioned for 2009."

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies, and Tools and Components (www.danaher.com).

Statements in this release that are not strictly historical, including statements regarding the range of earnings per share expectations for 2009, the Company's positioning for 2009 and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking" statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These factors include, among other things, the current economic recession and the upheaval in the credit markets and financial services industry, competition, our ability to develop and successfully market new products and technologies, our ability to expand our business in new markets, our ability to identify, consummate and integrate appropriate acquisitions, litigation and other contingent liabilities including intellectual property and environmental matters, our compliance with applicable laws and regulations and changes in applicable laws and regulations, tax audits and changes in our tax rate, currency exchange rates, commodity costs and surcharges, our relationships with and the performance of our channel partners, our ability to achieve projected efficiencies, cost reductions, sales growth and earnings, economic and other conditions in the end-markets we sell into, and general domestic and international economic conditions. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2007 Annual Report on Form 10-K and Third Quarter 2008 Quarterly Report on Form 10-Q. These forward-looking statements speak only as of the date of this release and the Company does not intend to update any forward-looking statement.


'/>"/>
SOURCE Danaher Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Danaher to Present at Goldman Sachs Global Industrials Conference
2. Danaher Corporation Schedules First Quarter Conference Call
3. Danaher to Present at Citigroup Global Industrial Manufacturing Conference
4. Danaher Closes Subsequent Offering Period for Tektronix; Acquires Over 90% of TEK Shares
5. American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours
6. Assurant Comments on A.M. Best Ratings Statement; Ratings Continue to Reflect Assurants Solid Financial Position
7. Consumer Watchdog Comments on Health Insurers Self-Serving Support of Individual Mandate
8. The Senior Citizens Leagues Comments on U.S. Supreme Court Case Wyeth v. Levine
9. Seyfarth Shaw Partner Camille A. Olson, Senate Witness for ADA Amendments Act, Comments on President's Signing of Bill into Law
10. Conscience Protections Essential to Healthcare System, Americans United for Life Argues in Comments Filed with HHS
11. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... MA (PRWEB) , ... September 26, 2017 , ... CGL ... its first office under its new umbrella, CGL Technologies, LLC. , The new CGL ... industry veterans Remo Patitucci and Jon McCormack, both of whom have creative business development ...
(Date:9/26/2017)... Church, VA (PRWEB) , ... September 26, 2017 , ... ... and Cerulean Associates LLC **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity ... investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy and ...
(Date:9/26/2017)... ... September 26, 2017 , ... DETECTO has been ... 1, 2017, the new agreement allows Premier members, at their discretion, to take ... “DETECTO is pleased to renew our agreement with Premier to be able to ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sound of My Song”: ... the creation of published author, Karmen Worden, a retired teacher with a passion for ... book is an intriguing and inspiring story on loss, living with depression, and finding ...
(Date:9/26/2017)... ... ... Saves Boobie and Ceebie”: a tool families can use to teach children about the love ... author, G.S. White, a devoted follower of Jesus Chris who is married with one son. ... not only for children but also to glorified God in everything he does.” --G.S. White ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
(Date:9/5/2017)... another milestone in their continued growth and success of the company.  Xyntek has ... engagements regionally.  ... at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will support the ... In addition to Xyntek,s headquarters ...
Breaking Medicine Technology: